• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CSMD1 全基因组关联精神分裂症风险变异 rs10503253 的神经认知影响。

Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.

机构信息

Neuropsychiatric Genetics Group, Department of Psychiatry, Institute of Molecular Medicine, Trinity College Dublin, St. James Hospital, Dublin, Ireland.

出版信息

Genes Brain Behav. 2013 Mar;12(2):203-9. doi: 10.1111/gbb.12016.

DOI:10.1111/gbb.12016
PMID:23320435
Abstract

The single-nucleotide polymorphism (SNP) rs10503253, located within the CUB and Sushi multiple domains-1 (CSMD1) gene on 8p23.2, was recently identified as genome-wide significant for schizophrenia (SZ), but is of unknown function. We investigated the neurocognitive effects of this CSMD1 variant in vivo in patients and healthy participants using behavioral and imaging measures of brain structure and function. We compared carriers and non-carriers of the risk 'A' allele on measures of neuropsychological performance typically impaired in SZ (general cognitive ability, episodic and working memory and attentional control) in independent samples of Irish patients (n = 387) and controls (n = 171) and German patients (205) and controls (n = 533). Across these groups, the risk 'A' allele at CSMD1 was associated with deleterious effects across a number of neurocognitive phenotypes. Specifically, the risk allele was associated with poorer performance on neuropsychological measures of general cognitive ability and memory function but not attentional control. These effects, while significant, were subtle, and varied between samples. Consistent with previous evidence suggesting that CSMD1 may be involved in brain mechanisms related to memory and learning, these data appear to reflect the deleterious effects of the identified 'A' risk allele on neurocognitive function, possibly as part of the mechanism by which CSMD1 is associated with SZ risk.

摘要

单核苷酸多态性(SNP)rs10503253 位于 8p23.2 上的 CUB 和 Sushi 多结构域-1(CSMD1)基因内,最近被确定为与精神分裂症(SZ)全基因组显著相关,但功能未知。我们使用脑结构和功能的行为和成像测量,在体内研究了该 CSMD1 变体在患者和健康参与者中的神经认知效应。我们在独立的爱尔兰患者(n = 387)和对照组(n = 171)和德国患者(205)和对照组(n = 533)样本中,比较了风险 'A' 等位基因携带者和非携带者在 SZ 中通常受损的神经心理表现(一般认知能力、情景和工作记忆以及注意力控制)的神经认知性能的测量值。在这些组中,CSMD1 的风险 'A' 等位基因与多种神经认知表型的有害影响有关。具体来说,风险等位基因与神经心理学一般认知能力和记忆功能的测量值较差有关,但与注意力控制无关。这些影响虽然显著,但很细微,并且在样本之间存在差异。与先前的证据一致,表明 CSMD1 可能参与与记忆和学习相关的大脑机制,这些数据似乎反映了已识别的 'A' 风险等位基因对神经认知功能的有害影响,可能是 CSMD1 与 SZ 风险相关的机制的一部分。

相似文献

1
Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.CSMD1 全基因组关联精神分裂症风险变异 rs10503253 的神经认知影响。
Genes Brain Behav. 2013 Mar;12(2):203-9. doi: 10.1111/gbb.12016.
2
The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males.CSMD1全基因组关联的精神分裂症风险变异rs10503253影响健康男性的一般认知能力和执行功能。
Schizophr Res. 2014 Apr;154(1-3):42-7. doi: 10.1016/j.schres.2014.02.017. Epub 2014 Mar 11.
3
Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.CSMD1 全基因组关联精神分裂症风险变异 rs10503253 的神经效应。
Am J Med Genet B Neuropsychiatr Genet. 2013 Sep;162B(6):530-7. doi: 10.1002/ajmg.b.32182. Epub 2013 Jul 10.
4
No association between the rs10503253 polymorphism in the CSMD1 gene and schizophrenia in a Han Chinese population.汉族人群中,CSMD1基因的rs10503253多态性与精神分裂症之间无关联。
BMC Psychiatry. 2016 Jul 4;16:206. doi: 10.1186/s12888-016-0923-5.
5
A genetic association study of CSMD1 and CSMD2 with cognitive function.CSMD1 和 CSMD2 基因与认知功能的关联研究。
Brain Behav Immun. 2017 Mar;61:209-216. doi: 10.1016/j.bbi.2016.11.026. Epub 2016 Nov 25.
6
Replicated association between the European GWAS locus rs10503253 at CSMD1 and schizophrenia in Asian population.欧洲全基因组关联研究(GWAS)中位于CSMD1基因座的rs10503253与亚洲人群精神分裂症之间的重复关联。
Neurosci Lett. 2017 Apr 24;647:122-128. doi: 10.1016/j.neulet.2017.03.039. Epub 2017 Mar 24.
7
CSMD1 rs10503253 increases schizophrenia risk in a Tunisian population-group.CSMD1 rs10503253 增加了突尼斯人群的精神分裂症风险。
Encephale. 2024 Aug;50(4):380-385. doi: 10.1016/j.encep.2023.08.002. Epub 2023 Sep 23.
8
Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models.CSMD1表达改变会改变可卡因诱导的位置偏爱:来自人类和小鼠模型对一个复杂基因座的相互支持。
PLoS One. 2015 Jul 14;10(7):e0120908. doi: 10.1371/journal.pone.0120908. eCollection 2015.
9
Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects.一氧化氮合酶1(NOS1)对精神分裂症患者和健康对照者言语智力及工作记忆的影响。
Arch Gen Psychiatry. 2009 Oct;66(10):1045-54. doi: 10.1001/archgenpsychiatry.2009.139.
10
The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up.主要组织相容性复合体区域在认知和大脑结构中的作用:一项精神分裂症 GWAS 的后续研究。
Am J Psychiatry. 2013 Aug;170(8):877-85. doi: 10.1176/appi.ajp.2013.12020226.

引用本文的文献

1
Potential Association of the Gene with Moderate Intellectual Disability, Anxiety Disorder, and Obsessive-Compulsive Personality Traits.该基因与中度智力残疾、焦虑症和强迫型人格特质之间的潜在关联。
Int J Mol Sci. 2025 May 1;26(9):4297. doi: 10.3390/ijms26094297.
2
Microglia and cognitive impairment in schizophrenia: translating scientific progress into novel therapeutic interventions.精神分裂症中的小胶质细胞与认知障碍:将科学进展转化为新型治疗干预措施
Schizophrenia (Heidelb). 2023 Jul 10;9(1):42. doi: 10.1038/s41537-023-00370-z.
3
Multi-ancestry phenome-wide association of complement component 4 variation with psychiatric and brain phenotypes in youth.
多民族人群补体成分 4 变异与青少年精神和脑表型的全表型关联研究。
Genome Biol. 2023 Mar 7;24(1):42. doi: 10.1186/s13059-023-02878-0.
4
The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases.CUB 和 Sushi 多结构域 1(CSMD1)在人类疾病中的多种作用。
Genes (Basel). 2022 Dec 10;13(12):2332. doi: 10.3390/genes13122332.
5
Overlap between genetic variants associated with schizophrenia spectrum disorders and intelligence quotient: a systematic review.与精神分裂症谱系障碍和智商相关的遗传变异重叠:系统综述。
J Psychiatry Neurosci. 2022 Nov 22;47(6):E393-E408. doi: 10.1503/jpn.220026. Print 2022 Nov-Dec.
6
Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability.补体成分 C4A 和 CSMD1 外周表达在首发精神病中的失调及其与认知能力的关系。
Eur Arch Psychiatry Clin Neurosci. 2022 Oct;272(7):1219-1228. doi: 10.1007/s00406-022-01409-5. Epub 2022 May 9.
7
New Insight into the human genetic diversity in North African populations by genotyping of SNPs in DRD3, CSMD1 and NRG1 genes.通过对 DRD3、CSMD1 和 NRG1 基因中的 SNP 进行基因分型,深入了解北非人群的人类遗传多样性。
Mol Genet Genomic Med. 2022 Mar;10(3):e1871. doi: 10.1002/mgg3.1871. Epub 2022 Feb 7.
8
Microglial-expressed genetic risk variants, cognitive function and brain volume in patients with schizophrenia and healthy controls.精神分裂症患者和健康对照者中微胶质细胞表达的遗传风险变异体、认知功能和脑容量。
Transl Psychiatry. 2021 Sep 23;11(1):490. doi: 10.1038/s41398-021-01616-z.
9
Aberrant Complement System Activation in Neurological Disorders.异常补体系统激活与神经退行性疾病。
Int J Mol Sci. 2021 Apr 28;22(9):4675. doi: 10.3390/ijms22094675.
10
Association between complement component 4A expression, cognitive performance and brain imaging measures in UK Biobank.英国生物银行中补体成分4A表达、认知表现与脑成像测量之间的关联
Psychol Med. 2021 Mar 3;52(15):1-11. doi: 10.1017/S0033291721000179.